The National National Task Force for COVID-19 of ICMR has made the decision to not include the antiviral drug Molnupiravir in the Clinical Management Protocol for now, official sources told news agency PTI on Tuesday (January 11).
from India News https://ift.tt/3tjewZ1
No comments:
Post a Comment